Breaking News Instant updates and real-time market news.

TSRO

TESARO

$99.26

-0.63 (-0.63%)

09:27
10/10/16
10/10
09:27
10/10/16
09:27

TESARO price target raised to $128 from $122 at RBC Capital

RBC Capital analyst Adnan Butt raised his price target on TESARO after ovarian cancer patients taking the company's Niraparib drug responded better than expected. Butt said that the drug benefited the patients regardless of BRCA or HRD biomarker status. He keeps an Outperform rating on the stock.

  • 06

    Nov

  • 11

    Jan

TSRO TESARO
$99.26

-0.63 (-0.63%)

10/10/16
LEER
10/10/16
NO CHANGE
Target $115
LEER
Outperform
TESARO price target raised to $115 after niraparib data at Leerink
Leerink analyst Seamus Fernandez said full results of TESARO's Phase 3 NOVA trial for niraparib as second-line maintenance for ovarian cancer presented at the ESMO meeting are strong enough to warrant approval in the overall patient population regardless of BRCAmut or HRD status. He increased his probability of approval in non-gBRCA/HRD-negative patients to 70% in the U.S., from 0%, and to 50% in the EU, from 0%. He raised his price target on TESARO shares to $115 from $108 per share and keeps an Outperform rating on the stock.
10/10/16
RAJA
10/10/16
NO CHANGE
Target $120
RAJA
Strong Buy
TESARO price target raised to $120 at Raymond James
Raymond James analyst Christopher Raymond raised TESARO's price target to $120 from $105 fter the company reported "clinically meaningful benefits in all the sub-populations" of the NOVA trial for niraparib. Raymond thinks niraparib will have a broad ovarian cancer label and corresponding market opportunity and reiterates his Strong Buy rating.
10/10/16
FBCO
10/10/16
NO CHANGE
Target $122
FBCO
Outperform
TESARO price target raised to $122 on Niraparib data at Credit Suisse
Credit Suisse analyst Alethia Young raised TESARO's price target to $122 from $90 after the company reported "clinically meaningful benefits in all the sub-populations" of the NOVA trial for niraparib. The analyst thinks niraparib has broad effects across the 2nd line ovarian population and would expect the label is broad. Young has an Outperform ratting n TESARO shares.
10/10/16
RAJA
10/10/16
NO CHANGE
Target $120
RAJA
Outperform
TESARO price target raised to $120 from $105 at Raymond James
Raymond James analyst Christopher Raymond raised TESARO's price target to $120 from $105 after the company reported "clinically meaningful benefits in all the sub-populations" of the NOVA trial for niraparib. Raymond thinks niraparib will have a broad ovarian cancer label and corresponding market opportunity and reiterates his Strong Buy rating

TODAY'S FREE FLY STORIES

KFRC

Kforce

$25.50

0.3 (1.19%)

05:15
02/24/17
02/24
05:15
02/24/17
05:15
Downgrade
Kforce rating change  »

Kforce downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$120.70

1.27 (1.06%)

05:14
02/24/17
02/24
05:14
02/24/17
05:14
Upgrade
Intuit rating change  »

Intuit upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$24.66

-0.12 (-0.48%)

05:13
02/24/17
02/24
05:13
02/24/17
05:13
Downgrade
HP Enterprise rating change  »

HP Enterprise downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$38.58

-2.68 (-6.50%)

05:13
02/24/17
02/24
05:13
02/24/17
05:13
Downgrade
Wayfair rating change  »

Wayfair downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTGC

Hercules Capital

$14.94

-0.49 (-3.18%)

05:12
02/24/17
02/24
05:12
02/24/17
05:12
Downgrade
Hercules Capital rating change  »

Hercules Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVR

Invesco Mortgage

$15.57

0.08 (0.52%)

05:12
02/24/17
02/24
05:12
02/24/17
05:12
Downgrade
Invesco Mortgage rating change  »

Invesco Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

REG

Regency Centers

$70.95

0.94 (1.34%)

, EQY

Equity One

$31.91

0.39 (1.24%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Equity One to host special shareholder meeting »

Special Shareholder…

REG

Regency Centers

$70.95

0.94 (1.34%)

EQY

Equity One

$31.91

0.39 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

MMM

3M

$187.19

1.15 (0.62%)

, BIOL

BIOLASE

$1.50

-0.02 (-1.32%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Chicago Dental Society to hold a meeting »

Chicago Dental Midwinter…

MMM

3M

$187.19

1.15 (0.62%)

BIOL

BIOLASE

$1.50

-0.02 (-1.32%)

COF

Capital One

$93.41

0.52 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$42.51

-1.83 (-4.13%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Rio Tinto management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 26

    Feb

EQY

Equity One

$31.91

0.39 (1.24%)

, REG

Regency Centers

$70.95

0.94 (1.34%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Regency Centers to host special shareholder meeting »

Special Shareholder…

EQY

Equity One

$31.91

0.39 (1.24%)

REG

Regency Centers

$70.95

0.94 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

CASM

CAS Medical

$1.48

-0.01 (-0.67%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
CAS Medical management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

PBNC

Paragon Commercial

$50.50

-0.35 (-0.69%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Paragon Commercial management to meet with Sandler O'Neill »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SC

Santander Consumer

$14.33

-0.12 (-0.83%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Santander Consumer management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

ELNK

EarthLink

$5.85

0.04 (0.69%)

, WIN

Windstream

$7.29

0.07 (0.97%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Windstream to host special shareholder meeting »

Virtual Special…

ELNK

EarthLink

$5.85

0.04 (0.69%)

WIN

Windstream

$7.29

0.07 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 01

    Mar

  • 06

    Mar

GIS

General Mills

$60.78

0.19 (0.31%)

, TSN

Tyson Foods

$62.82

-0.4 (-0.63%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
The Consumer Analyst Group of New York to hold a conference »

2017 CAGNY Conference is…

GIS

General Mills

$60.78

0.19 (0.31%)

TSN

Tyson Foods

$62.82

-0.4 (-0.63%)

TWNK

Hostess Brands

$15.78

0.31 (2.00%)

MJN

Mead Johnson

$87.61

0.11 (0.13%)

K

Kellogg

$74.80

0.31 (0.42%)

MDLZ

Mondelez

$44.89

0.24 (0.54%)

INGR

Ingredion

$122.28

1.66 (1.38%)

LNCE

Snyder's-Lance

$39.60

0.17 (0.43%)

SYY

Sysco

$52.89

0.14 (0.27%)

JNJ

Johnson & Johnson

$120.90

2.18 (1.84%)

SJM

J.M. Smucker

$140.83

0.1 (0.07%)

MO

Altria Group

$74.46

0.86 (1.17%)

CPB

Campbell Soup

$59.06

-0.11 (-0.19%)

PEP

PepsiCo

$109.54

0.13 (0.12%)

CLX

Clorox

$135.83

-0.09 (-0.07%)

BG

Bunge

$80.05

0.61 (0.77%)

PG

Procter & Gamble

$91.13

-0.31 (-0.34%)

DANOY

Danone

$13.34

0.13 (0.98%)

SPB

Spectrum Brands

$137.26

0.97 (0.71%)

KO

Coca-Cola

$41.66

0.06 (0.14%)

IFF

International Flavors

$125.14

2.51 (2.05%)

STZ

Constellation Brands

$153.60

-6.6 (-4.12%)

NSRGY

Nestle

$74.20

0.4 (0.54%)

CHD

Church & Dwight

$49.62

-0.07 (-0.14%)

UN

Unilever; also tag UL

$46.58

-0.17 (-0.36%)

CL

Colgate-Palmolive

$74.44

0.95 (1.29%)

NWL

Newell Brands

$46.80

-0.26 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 09

    Mar

  • 14

    Mar

  • 15

    Mar

  • 19

    Mar

  • 27

    Mar

  • 09

    May

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
CLSA to hold a forum »

Japan Forum is being held…

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
CLSA financial tech analyst holds an analyst/industry conference call »

Financial Technology…

AGN

Allergan

$246.33

0.71 (0.29%)

, EDGE

Edge Therapeutics

$10.00

-0.27 (-2.63%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
American Heart Association to hold a conference »

International Stroke…

AGN

Allergan

$246.33

0.71 (0.29%)

EDGE

Edge Therapeutics

$10.00

-0.27 (-2.63%)

AMGN

Amgen

$174.01

1.4 (0.81%)

ATRC

AtriCure

$17.35

0.13 (0.75%)

BMY

Bristol-Myers

$55.77

0.42 (0.76%)

DNA

Bought by RHHBY

MDCO

The Medicines Co.

$51.84

-0.38 (-0.73%)

MDT

Medtronic

$80.74

1.12 (1.41%)

MRK

Merck

$65.85

0.56 (0.86%)

PH

Parker-Hannifin

$153.70

-2.16 (-1.39%)

PTLA

Portola Pharmaceuticals

$32.16

0.02 (0.06%)

Q

QuintilesIMS

$78.12

0.77 (1.00%)

SSNLF

Samsung

SAY

Satyam

TWTR

Twitter

$16.03

-0.05 (-0.31%)

WTKWY

Wolters Kluwer

$40.39

0.502 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 02

    Mar

  • 07

    Mar

  • 08

    Mar

  • 09

    Mar

  • 15

    Mar

  • 17

    Mar

  • 19

    Mar

  • 21

    Mar

  • 28

    Mar

  • 01

    Apr

  • 04

    May

  • 10

    May

  • 27

    May

  • 14

    Jun

  • 24

    Jun

  • 19

    Jul

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Wells Fargo housing analyst holds an analyst/industry conference call »

Senior Housing Analyst…

NVO

Novo Nordisk

$35.78

0.53 (1.50%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Novo Nordisk management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 07

    Mar

KAR

KAR Auction

$44.50

-0.3 (-0.67%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
KAR Auction management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 13

    Mar

  • 14

    Mar

  • 15

    Mar

04:55
02/24/17
02/24
04:55
02/24/17
04:55
General news
Consumer Sentiment Index to be reported at 10:00 »

February Consumer…

04:55
02/24/17
02/24
04:55
02/24/17
04:55
General news
New Home Sales to be reported at 10:00 »

January New Home Sales…

VWDRY

Vestas

$25.08

0.175 (0.70%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Vestas management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

HSIC

Henry Schein

$171.92

-0.72 (-0.42%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Henry Schein management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.